Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma
ClinicalTrials.gov study NCT00847639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
ClinicalTrials.gov study NCT05346809. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment
ClinicalTrials.gov study NCT05858203. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The TOTOM Trial: Tai Chi to Optimize Transplant Outcomes for Multiple Myeloma
ClinicalTrials.gov study NCT04760405. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cost-utility Analysis of Ambulatory Dose Escalation of Bispecific Antibodies in Multiple Myeloma.
ClinicalTrials.gov study NCT06846905. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01234129. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04756401. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib
ClinicalTrials.gov study NCT02294357. IPD Sharing: NO. Countries: 1. Publications: 0.
Revlimid® Capsules Special Drug Use-results Survey (in Patients With Newly-diagnosed Multiple Myeloma [NDMM])
ClinicalTrials.gov study NCT02741544. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Microtransplantation Versus Auto-SCT in ≥PR Multiple Myeloma Patients
ClinicalTrials.gov study NCT02981199. IPD Sharing: NO. Countries: 1. Publications: 0.
A Safety Study of SGN-CD48A in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT03379584. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01537861. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma.
ClinicalTrials.gov study NCT04667663. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma
ClinicalTrials.gov study NCT00378768. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nonmyeloablative Allogeneic Stem Cell Transplant Followed by Bortezomib in High-risk Multiple Myeloma Patients
ClinicalTrials.gov study NCT02308280. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of BMS-986453 in Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT07333261. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of BL-M24D1 in Patients With Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies
ClinicalTrials.gov study NCT07255898. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients
ClinicalTrials.gov study NCT07210047. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04674813. IPD Sharing: YES. Countries: 1. Publications: 0.
A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma
ClinicalTrials.gov study NCT05620420. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.